{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-11-02T15%3A16%3A11.890Z&houseId=1&tablingMemberConstituency=Washington+and+Sunderland+West&dateTabled=2014-11-07", "items" : [{"_about" : "http://data.parliament.uk/resources/143395", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/143395/answer", "answerText" : {"_value" : "
The Department is continuing negotiations for the supply of the meningococcal B vaccine Bexsero®<\/sup> with the manufacturer Novartis with a view to securing a cost-effective price as recommended by the Joint Committee on Vaccination and Immunisation.<\/p> <\/p> <\/p> <\/p> Plans for inclusion of the Bexsero®<\/sup> in the routine infant immunisation programme will depend on the outcome of these negotiations, which will be completed as quickly as practicable.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-11-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-19T16:08:45.727Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Meningitis: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what timescale his Department has set for rolling out the meningococcal group B vaccine Bexsero to all babies as part of the national immunisation programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213865"}
, {"_about" : "http://data.parliament.uk/resources/143396", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/143396/answer", "answerText" : {"_value" : " Work is under way by Departmental officials to explore a possible acquisition of a carriage study, as suggested by the Joint Committee on Vaccination and Immunisation.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-11-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-19T16:16:44.583Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Meningitis: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if his Department will commission a carriage study into whether the meningococcal group B vaccine Bexsero should be extended and administered to adolescents and students.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213866"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}